Decellularized Dermis 40 mm x 70 mm x 3.0 mm

Finished Product

AFLEX301

Human

Orthobiologics

Product

Procedure

ArthroFlex dermal allograft is an acellular dermal extracellular matrix intended for supplemental support and covering for soft-tissue repair. MatrACELL®* technology, a patented and validated process, renders the ArthroFlex allograft dermis acellular without compromising biomechanical or biochemical properties. This process allows the matrix to retain its growth factors, native collagen scaffold, and elastin, which are required for healing.1 Arthroflex dermal allograft improves the strength of the repair and protects it to allow healing.2,3 MatrACELL technology removes donor DNA from the dermal matrix, ensuring a biocompatible scaffold to facilitate repair.
References:
1. Moore MA, Samsell B, Wallis G. Cell Tissue Bank. 2015;16(2):249-259. doi:10.1007/s10561-014-9467-4.
2. Gilot GJ, Alvarez-Pinzon AM, Barcksdale L, Westerdahl D, Krill M, Peck E. Arthroscopy. 2015;31(8):1459-65. doi:10.1016/j.arthro.2015.02.032
3. Ely EE, Figueroa NM, Gilot GJ. Orthopedics. 2014;37(9):608-614. doi:10.3928/01477447-20140825-05
*ArthroFlex and MatrACELL are registered trademarks of LifeNet Health.

Rotator Cuff Healing Index (RoHI) Risk Factors

ArthroFLEX® Decellularized Dermal Allograft

Child (D)

Foot and Ankle

ArthroFLEX® is an acellular dermal extracellular matrix intended for supplemental support and covering for soft tissue repair. MATRACELL, a patented and validated process by LifeNet Health, renders the ArthroFLEX allograft dermis acellular, without compromising biomechanical or biochemical properties. This process allows the matrix to retain its growth factors, native collagen scaffold and elastin, which is required for healing. Elastin and collagen provide unparalleled strength for supplemental support and covering for soft tissue repair. MATRACELL removes donor DNA from the dermal matrix, ensuring a biocompatible scaffold to facilitate repair. An intact acellular matrix of collagen, elastin and growth factors provides a clean scaffold intended for supplemental support and covering for soft tissue repair.

ArthroFLEX® Decellularized Dermal Allograft

Shoulder

The SCR technique was pioneered by Dr. Teruhisa Mihata in 2007 for patients with irreparable rotator cuff tears. In the SCR study, a 24- to 51-month follow-up on 23 patients shows outstanding outcomes in pain, ASES scores, and acromiohumeral distance measurements.1 The SCR technique reinforces the superior capsule, keeping the humeral head centered in the glenoid by attaching tissue from the glenoid to the greater tuberosity.
Reference
1. Mihata T, Lee TQ, Watanabe C, et al. Clinical results of arthroscopic superior capsule reconstruction for irreparable rotator cuff tears. Arthroscopy. 2013;29(3):459-470. doi:10.1016/j.arthro.2012.10.022

Decellularized Dermis 40 mm x 70 mm x 3.0 mm

AFLEX301

Related Pages

Orthobiologics

ArthroFLEX^® Decellularized Dermal Allograft

Product

Foot and Ankle

ArthroFLEX^® Decellularized Dermal Allograft

Product

Shoulder

Superior Capsular Reconstruction (SCR) Technique

Procedure